Investigation of changes in ankylosing spondylitis disease activity through 2021 COVID-19 wave in Taiwan by using electronic medical record management system
Open Access
- 7 January 2023
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 13 (1) , 1-8
Abstract
We aim to investigate the alteration in disease activity of ankylosing spondylitis (AS) individuals before, during, and after the COVID-19 wave in Taiwan by using electronic medical-record management system (EMRMS). We identified 126 AS individuals from the single center, and gathered data of the three disease activities (Bath Ankylosing Spondylitis Disease Activity Index [BASDAI], Ankylosing Spondylitis Disease Activity Score with erythrocyte sedimentation rate [ASDAS-ESR], and Ankylosing Spondylitis Disease Activity Score with C-Reactive Protein [ASDAS-CRP]) by using EMRMS before (7 February to 1 May, 2021), during (2 May to 24 July, 2021), and after the COVID-19 wave (25 July to 16 October, 2021). We compared the disease activity measures of the three phases through a paired t test. Among the 126 individuals, CRP was significantly higher during the COVID-19 wave (0.2 (0.1, 0.5) mg/dl, p = 0.001) than before the wave (0.2 (0.1, 0.4) mg/dl), ESR (8.0 (4.0, 15.0) mm/h, p = 0.003) and ASDAS-ESR (1.4 (1.0, 1.9), p = 0.032) were significantly higher after the wave than during the wave (6.0 (3.0, 12.0) mm/h and 1.2 (0.9, 1.8) mm/h) e. ESR, CRP, ASDAS-ESR and ASDAS-CRP were all significant higher after COVID-19 wave than before. The disease activities of AS individuals in Taiwan worsened after 2021 COVID-19 wave in Taiwan.Keywords
This publication has 21 references indexed in Scilit:
- Gender difference in ASAS HI among patients with ankylosing spondylitisPLOS ONE, 2020
- What is axial spondyloarthritis? A latent class and transition analysis in the SPACE and DESIR cohortsAnnals of the Rheumatic Diseases, 2020
- Ankylosing Spondylitis Disease Activity Score (ASDAS): 2018 update of the nomenclature for disease activity statesAnnals of the Rheumatic Diseases, 2018
- Effectiveness, acceptability and usefulness of mobile applications for cardiovascular disease self-management: Systematic review with meta-synthesis of quantitative and qualitative dataEuropean Journal of Preventive Cardiology, 2018
- 2016 update of the ASAS-EULAR management recommendations for axial spondyloarthritisAnnals of the Rheumatic Diseases, 2017
- SAT0512 Comparison of Asdas ESR/ASDAS CRP with Basdai and Clinical Disease Activity in Enthesitis Related ArthritisAnnals of the Rheumatic Diseases, 2015
- Comparison of ASDAS and BASDAI as a measure of disease activity in axial psoriatic arthritisClinical Rheumatology, 2014
- Ankylosing Spondylitis Disease Activity Score (ASDAS): defining cut-off values for disease activity states and improvement scoresAnnals of the Rheumatic Diseases, 2011
- Impact of Age, Sex, Physical Function, Health-related Quality of Life, and Treatment with Adalimumab on Work Status and Work Productivity of Patients with Ankylosing SpondylitisThe Journal of Rheumatology, 2009
- Patient- versus physician-reported outcomes in rheumatoid arthritis patients treated with recombinant interleukin-1 receptor antagonist (anakinra) therapyRheumatology, 2004